Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification
This rapid test device is an in vitro diagnostic tool for the simultaneous detection of key hemoglobin phenotypes associated with Sickle Cell Disease: HA (normal hemoglobin), HS (sickle cell trait/carrier), and HC (sickle cell disease). Utilizing advanced immunochromatographic technology, it provides a rapid and reliable qualitative screening result from a small blood sample.
Intended Use & Application Scenarios
- Newborn Screening: For early detection and risk assessment of sickle cell disease
- Pre-marital / Pre-conception Screening: To evaluate genetic carrier status and inform family planning decisions
- Clinical Symptom Triage: As an aid in diagnosing patients presenting with anemia, jaundice, unexplained pain (vaso-occlusive crisis), or growth delays
- Multi-Scenario Adaptability: Suitable for at-home self-testing, initial screening in primary healthcare facilities, and large-scale procurement by public health departments for epidemiological surveillance
Core Features & Advantages
- Triple-Target Synchronous Detection: Identifies HA, HS, and HC status in a single test, enabling precise phenotypic differentiation
- High Sensitivity & Specificity: Engineered for accurate detection of hemoglobin variants, delivering stable and dependable results
- Rapid & User-Friendly: Requires no specialized equipment; delivers clear visual results within minutes
- Versatile Utility: Designed to meet diverse needs—from individual self-care to institutional screening programs